Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Following conjugation to peptide antigens or incorporation with an immune checkpoint inhibitor, poly-ICLC demonstrated strong adjuvanticity and dendritic cell targeting in phase I/II clinical trials for TNBC, colon, glioblastoma, and ovarian cancer
By this point, purging should have resolved or significantly improved
With the development of minimally invasive techniques, most patients with kidney stones opt for surgical treatment
Onger ME, Kaplan S, Deniz OG, et al
The findings from this study may pave the way for the development of targeted interventions for reproductive disorders, potentially improving the quality of life for individuals affected by these conditions
US$ 25.65
US$ 21.79
US$ 24.21
